Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis

Case Study of the Treatment of Early Rheumatoid Arthritis in Algerian Patients in Both the Private and Public Healthcare Sectors.

This non-interventional, descriptive, cross-sectional and multicenter study will examine the treatment of rheumatoid arthritis progressing for less than two years in the Algerian population. Current drug therapy as well as disease status and patient function will be assessed.

Inclusion Criteria:

• Rheumatoid arthritis progressing for < 2 years.

Exclusion Criteria:

• Rheumatoid arthritis progressing for < 3 months.
• Rheumatoid arthritis onset at < 18 years of age.
• Participation in another clinical study.
• Rheumatoid arthritis related connective tissue disorder.
• Any neuropsychological disorders.